ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
ABIOMED Inc.
-(ABMD)
XNAS:ABMD
Is it the right time to invest in Abiomed (ABMD) stock?
Medical devices like ventilators and personal protective equipment are in high demand during the pandemic and their shortage often adds to the
Abiomed, Inc. (ABMD) Q1 2022 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q1 2022 earnings call dated Aug. 05, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Earnings calendar for the week of August 2
Labor market conditions improved once again and jobless claims dropped to about 400,000 after rising last week, as economic activity picked up.
Abiomed, Inc. (ABMD) Q4 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q4 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Earnings calendar for the week of April 26
Investor sentiment was hit by the government's proposal to levy higher capital gain tax on wealthy individuals, and the market shifted to
Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Earnings calendar for the week of January 11
Stock markets responded positively to the latest developments in presidential election. On the heels of the Dow Jones Industrial Average achieving a
Abiomed Inc (NASDAQ: ABMD) Q4 2020 Earnings Call Transcript
Abiomed Inc (ABMD) Q4 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Todd A.Trapp -- Vice President and Chief Financial Officer Michael R.
Infographic: Highlights of Abiomed (ABMD) Q4 2020 earnings report
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Call Transcript
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Conference Call February 06, 2020 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Abiomed (ABMD): A look at what lies ahead for this medical device company
Shares of Abiomed Inc. (NASDAQ: ABMD) were down 4% in afternoon trade on Wednesday. The stock has dropped 22% over the past
Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot
-- Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter
Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook
Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella heart pumps.
Abiomed’s stock plunges to new 52-week low on Q4 revenue miss
Abiomed’s (NASDAQ: ABMD) stock plunged about 17% in the pre-market trading as the company failed to meet top-line estimates. It touched a